Thomas A. MCCOURT - 07 Jun 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 16:02:18 UTC
Previous filing
26 May 2021
Next filing
22 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +104,690 +18% $0.000000 671,189 07 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award, granted as a new Chief Executive Officer award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.